Full name
ARTFARM PROLEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
30.11.Z - Manufacture of civilian ships and floating structures
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
77.34.Z - Rental and leasing of water transport equipment
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,2 | 0,8 | 1,2 | 50,7 |
Gross profit (loss) | 1,5 | 0,7 | 1,2 | 59,5 |
EBITDA | 1,5 | 0,8 | 1,2 | 56,5 |
Short time liabilities | 1,9 | 1,9 | 2,1 | 13,5 |
Other operating costs | 0 | 0,1 | 0,1 | -0,5 |
Equity capital | 3,1 | 2,4 | 3,3 | 36,1 |
Operating profit (EBIT) | 1,5 | 0,7 | 1,2 | 59,1 |
Assets | 5 | 4,3 | 5,4 | 26,1 |
Net profit (loss) | 1,5 | 0,7 | 1,2 | 59,5 |
Cash | 1,1 | 1,3 | 1,8 | 35,7 |
Net income from sale | 16,8 | 18,3 | 20,2 | 10 |
Liabilities and provisions for liabilities | 1,9 | 1,9 | 2,1 | 13,5 |
Working assets | 5 | 4,2 | 5,4 | 26,4 |
Other income costs | 0,3 | 0 | 0,1 | 68,6 |
Depreciation | 0 | 0 | 0 | -70 |
% | % | % | p.p. | |
Profitability of capital | 47,1 | 31 | 36,3 | 5,3 |
Equity capital to total assets | 62,2 | 56 | 60,4 | 4,4 |
Gross profit margin | 8,8 | 4,1 | 5,9 | 1,8 |
EBITDA Margin | 9 | 4,1 | 5,9 | 1,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 41 | 37 | 39 | 2 |
Current financial liquidity indicator | 2.6272785663604736 | 2.2573306560516357 | 2.5142955780029297 | 0,2 |
Net dept to EBITDA | -0.6165391206741333 | -1.6120237112045288 | -1.474644660949707 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane